Edward Gill, MD
Cardiovascular Disease · Aurora, CONPI 1518046275
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $71,350 of the $96,170 with a category attached, or 74.2%. Philips North America LLC accounts for 95.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $23,930 and has fallen 55.0% since, to $10,770 in 2025. Among cardiovascular disease clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $620.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$92K
- Edwards Lifesciences$3K
- Abbott$306
- Amgen$238
- Boston Scientific$210
- Kaneka Medical America LLC$210
- plus $459 from 6 others
What the payments were for
- Speaking & faculty fees$71,35074%
- Travel & lodging$20,42121%
- Food & beverage$4,3995%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 105 | $91,829 |
| Edwards Lifesciences | 24 | $2,918 |
| Abbott | 2 | $306 |
| Amgen | 3 | $238 |
| Boston Scientific | 11 | $210 |
| Kaneka Medical America LLC | 1 | $210 |
| Sanofi-aventis U.S. LLC | 3 | $146 |
| Regeneron Healthcare Solutions, Inc. | 1 | $102 |
| Regeneron | 1 | $99 |
| E.r. Squibb & Sons, L.L.C. | 2 | $77 |
| Medtronic | 1 | $17 |
| Angiodynamics, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (1658) Clinical Educ Ultrasound$31,406
- US Undivided Serv$22,104
- Educ Ultrasound$21,847
- Clin Educ US$7,046
- RS Ultrasound undiv$3,824
- (7881) Ultrasound Und$3,000
- EVOQUE$928
- US Und$286
- EPIQ CVx$270
- MitraClip$158
- EPIQ 7C$150
- TRICLIP$148
- PASCAL$119
- EVKEEZA$102
How this compares
$96,170 in reported general payments places this provider in the 95th percentile of 276 cardiovascular disease providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CamzyosMavacamten | 32 | $247,664 |
| EliquisApixaban | 37 | $55,796 |
| EntrestoSacubitril/Valsartan | 30 | $46,240 |
| JardianceEmpagliflozin | 20 | $33,247 |
| Metoprolol Succinate | 150 | $2,914 |
| Bumetanide | 17 | $2,068 |
| Rosuvastatin Calcium | 86 | $1,938 |
| Ezetimibe | 25 | $646 |
| Verapamil ErVerapamil Hcl | 12 | $642 |
| Atorvastatin Calcium | 67 | $586 |
| Torsemide | 16 | $506 |
| Losartan Potassium | 51 | $406 |
| Spironolactone | 38 | $373 |
| Metoprolol Tartrate | 49 | $355 |
| Lisinopril | 37 | $328 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| E.r. Squibb & Sons, L.L.C.Camzyos | $77 | $247,66432 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 276 cardiovascular disease providers in Colorado.
Other cardiovascular disease in Aurora
- Payal KohliAurora$1.7M
- Marc BonacaAurora$703K
- William SauerAurora$365K
- Rhonda MiyasakaAurora$128K
- Gregory SchwartzAurora$122K
- Joseph AdewumiAurora$61K
- Charles FuenzalidaAurora$30K
- Christina HealyAurora$25K
- Sundeep ViswanathanAurora$21K
- Nelson PragerAurora$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.